|
1
|
Tabák AG, Herder C, Rathmann W, Brunner EJ
and Kivimäki M: Prediabetes: A high-risk state for developing
diabetes. Lancet. 379:2279–2290. 2012. View Article : Google Scholar
|
|
2
|
Weir MR: Salt, hypertension, and
proteinuria in diabetic nephropathy. Lancet Diabetes Endocrinol.
2:351–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dragun D, Philippe A, Catar R and Hegner
B: Autoimmune mediated G-protein receptor activation in
cardiovascular and renal pathologies. Thromb Haemost. 101:643–648.
2009.PubMed/NCBI
|
|
4
|
Smith SO: Structure and Activation of the
Visual Pigment Rhodopsin. Ann Rev Biophys. 39:309–328. 2010.
View Article : Google Scholar
|
|
5
|
Hilme E, Hansson L, Sanberg L, Söderström
T and Herlitz H: Abnormal immune function in malignant
hypertension. J hyper tens. 11:989–994. 1993. View Article : Google Scholar
|
|
6
|
Dragun D, Philippe A, Catar R and Hegner
B: Autoimmune mediated G-protein receptor activation in
cardiovascular and renal pathologies. Thromb Haemost. 101:643–648.
2009.PubMed/NCBI
|
|
7
|
Sun YX, Zhu F, Wang M, Li ZZ and Liao YH:
Increased autoantibody production against AT(1)-receptors and
alpha(1)-adrenergic receptors in hypertensive patients. Zhonghua
Xin Xue Guan Bing Za Zhi. 36:16–19. 2008.(In Chinese). PubMed/NCBI
|
|
8
|
Zhao LS, Xiang GD, Yue L, Liao YH, Zhou ZH
and Sun HL: Clinical effects of valsartan treatment on refractory
hypertension with the positive autoantibody of AT1 receptor in
diabetes mellitus patients. Chin J Diabetes. 16:607–610. 2008.(In
Chinese).
|
|
9
|
Zhao LS, Bai WW, Xiang GD, Yue L and Sun
HL: Clinical evaluation of valsartan and metoprolol tartrate in
treatment of diabetic nephropathy with positive beta1-adrenergic
and anti-angiotensin II type 1 receptor antibody. Chin Med J
(Engl). 125:3543–3547. 2012.
|
|
10
|
Qiu Y, Zhu F, Liao YH, Li ZZ and Wang M:
Association between positive autoantibodies against AT1-receptor
and cardiac remodeling in patients with hypertension. Zhonghua Xin
Xue Guan Bing Za Zhi. 35:1141–1144. 2007.
|
|
11
|
Zhu F, Sun YX, Liao YH, Wei YM, Chen M,
Wang M and Zhou ZH: Agonistic AT(1) receptor autoantibody increases
in serum of patients with refractory hypertension and improves
Ca(2+) mobilization in cultured rat vascular smooth muscle cells.
Cell Mol Immunol. 5:209–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LD, Tian M, Liao YH, Zhou ZH, Wei F,
Zhu F, Wang M, Wang B and Wei YM: Effect of active immunization
against angiotensin II type 1 (AT1) receptor on hypertension &
arterial remodelling in spontaneously hypertensive rats (SHR).
Indian J Med Res. 139:619–624. 2014.PubMed/NCBI
|
|
13
|
Wangensteen R, O’Valle F, Del MR, Vargas F
and Osuna A: Chronic alpha1-adrenergic blockade improves
hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA
hypertensive rats. Med Sci Monit. 8:378–384. 2002.
|
|
14
|
Chalmers J: The 1999 WHO-ISH Guidelines
for the Management of Hypertension. Med J Australia.
171:4581999.
|
|
15
|
Mogensen MM, Tucker JB and Stebbings H:
Microtubule polarities indicate that nucleation and capture of
microtubules occurs at cell surfaces in Drosophila. J Cell Biol.
108:1445–1452. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT
and Cheng LX: Autoantibodies against AT1 receptor and α1 adrenergic
receptor in patients with hypertension. Hypertens Res. 25:641–646.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Writing group of 2010 Chinese guidelines
for the management of hypertension. 2010 Chinese guidelines for the
management of hypertension. Chin J Hypertens. 19:701–743. 2011.
|
|
18
|
Wallukat G and Schimke I: Agonistic
autoantibodies directed against G-protein-coupled receptors and
their relationship to cardiovascular diseases. Semin Immunopathol.
36:351–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi L and Javitch JA: The binding site of
aminergic G protein-coupled receptors: the transmembrane segments
and second extracellular loop. Annu Rev Pharmacol Toxicol.
42:437–467. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Piali L and Richardson DR: G-protein
coupled receptors: drug targets of key importance. Curr Top Med
Chem. 11:6082011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thomas GN, Chan P and Tomlinson B: The
role of angiotensin II type 1 receptor antagonists in elderly
patients with hypertension. Drug Aging. 23:131–155. 2006.
View Article : Google Scholar
|
|
22
|
Randle LE, Sathish JG, Kitteringham NR,
Macdonald I, Williams DP and Park BK: alpha(1)-Adrenoceptor
antagonists prevent paracetamol-induced hepatotoxicity in mice. Br
J Pharmacol. 153:820–830. 2008. View Article : Google Scholar
|
|
23
|
Zhou ZH, Qi Q, Liao YH, Wang B, Li LD, Wei
F, Wang M and Wei YM: Preparation of the antibodies against alpha
1-adrenergic receptor with exciting actions. Chinese J Clin
Rehabil. 10:51–54. 2006.(In Chinese).
|
|
24
|
Iwata M, Yoshikawa T, Baba A, Anzai T,
Nakamura I, Wainai Y, Takahashi T and Ogawa S: Autoimmunity against
the second extracellular loop of beta(1)-adrenergic receptors
induces beta-adrenergic receptor desensitization and myocardial
hypertrophy in vivo. Circ Res. 88:578–586. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu ML, Herlitz H, Schulze W, et al:
Autoantibodies against the angiotensin receptor (AT1) in patients
with hypertension. J Hypertens. 18:945–953. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ogihara T, Asano T, Ando K, et al:
Angiotensin II-induced insulin resistance is associated with
enhanced insulin signaling. Hypertension. 40:872–879. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Touyz RM and Schiffrin EL: Signal
transduction mechanisms mediating the physiological and
pathophysiological actions of angiotensin II in vascular smooth
muscle cells. Pharmacol Rev. 52:639–672. 2000.PubMed/NCBI
|
|
28
|
Dzielak DJ: Immune mechanisms in
experimental and essential hypertension. Am J Physiol.
260:R459–R467. 1991.PubMed/NCBI
|
|
29
|
Shen KP, Lin HL, Hsieh SL, Kwan AL, Chen
IJ and Wu BN: Eugenosedin-A prevents hyperglycaemia,
hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a
high-fat diet. J Pharm Pharmacol. 61:517–525. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liao CH, Guh JH, Chueh SC, et al:
Anti-angiogenic effects and mechanism of prazosin. Prostate.
71:976–984. 2011. View Article : Google Scholar : PubMed/NCBI
|
